Annenberg Center for Health Sciences

Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM

Explore the latest research advancements in myasthenia gravis treatment, focusing on improving patient quality of life and addressing therapy limitations with expert insights.

Wrap Up

2 mins • Nov 19, 2024

Charts

This show is not currently ranked in any charts.

Recent Episodes

Nov 19, 2024

Wrap Up

2 mins

Nov 19, 2024

Long-Term Safety and Efficacy of Zilucoplan in Generalized Myasthenia Gravis 120-Week Interim Analysis of RAISE-XT

3 mins

Nov 19, 2024

Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 VIVACITY-MG3 Study

3 mins

Nov 19, 2024

Concomitant Corticosteroid Use with Ravulizumab in Adults with Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Phase 3 CHAMPION-MG Open-Label Extension Final Results

3 mins

Nov 19, 2024

Cyclic and Every-Other-Week Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis Part A of ADAPT NXT

3 mins

Language

English

Country

United States